OTCQB
BNXTF

BNXTF

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

BNXTF Stock Price

Vitals

Today's Low:
$0.2918
Today's High:
$0.3118
Open Price:
$0.3118
52W Low:
$0.0014
52W High:
$0.581
Prev. Close:
$0.2878
Volume:
1925

Company Statistics

Market Cap.:
$54.90 million
Book Value:
-0.045
Revenue TTM:
$297442
Operating Margin TTM:
0%
Gross Profit TTM:
$199478
Profit Margin:
0%
Return on Assets TTM:
-72.46%
Return on Equity TTM:
-397.02%

Company Profile

BNXTF had its IPO on under the ticker symbol BNXTF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. BNXTF has a staff strength of 0 employees.

Stock update

Shares of BNXTF opened at $0.31 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.29 - $0.31, and closed at $0.29.

This is a +1.39% increase from the previous day's closing price.

A total volume of 1,925 shares were traded at the close of the day’s session.

In the last one week, shares of BNXTF have slipped by -6.23%.

BNXTF's Key Ratios

BNXTF has a market cap of $54.90 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months BNXTF’s revenue was $297442 with a gross profit of $199478 and an EBITDA of $-6404293. The EBITDA ratio measures BNXTF's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BNXTF’s operating margin was 0% while its return on assets stood at -72.46% with a return of equity of -397.02%.

In Q1, BNXTF’s quarterly earnings growth was a positive 0% while revenue growth was a negative 77.1%.

BNXTF’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BNXTF’s profitability.

BNXTF stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

BNXTF stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$3.19 million
Total Liabilities
$3.28 million
Operating Cash Flow
$0
Capital Expenditure
$1567
Dividend Payout Ratio
0%

BNXTF ended 2024 with $3.19 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.19 million while shareholder equity stood at $-2346308.00.

BNXTF ended 2024 with $0 in deferred long-term liabilities, $3.28 million in other current liabilities, in common stock, $-56097172.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.89 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $2.26 million.

BNXTF’s total current assets stands at $2.31 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $338488.00 compared to accounts payable of $147972.00 and inventory worth $0.

In 2024, BNXTF's operating cash flow was $0 while its capital expenditure stood at $1567.

Comparatively, BNXTF paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.29
52-Week High
$0.581
52-Week Low
$0.0014
Analyst Target Price
$

BNXTF stock is currently trading at $0.29 per share. It touched a 52-week high of $0.581 and a 52-week low of $0.581. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.3 and 200-day moving average was $0.39 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 695.1% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About BNXTF

The stock symbol (also called stock or share ticker) of BNXTF is BNXTF

The IPO of BNXTF took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$0.47
0
+0.86%
Nedbank Group (NDBKY)
$11.2
0.22
+2%
$39.49
0.57
+1.46%
BHPA Inc (BHPA)
$0.01
0
0%
$30.11
-0.27
-0.89%
$1.41
0.06
+4.44%
$2.83
-0.08
-2.75%
$18.8
0
0%
$12.96
0.04
+0.31%
$0.22
-0
-1.14%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, the United States, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Address